Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Cidara Therapeutics, Inc. (CDTX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/14/2023 |
4
| Tari Leslie (CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on Cidara Therapeutics, Inc.|
Txns:
| Bought 10,000 shares
@ $0.97, valued at
$9.7k
|
|
| 08/08/2023 |
4
| Stein Jeffrey (President & CEO) has filed a Form 4 on Cidara Therapeutics, Inc.|
Txns:
| Bought 50,000 shares
@ $0.9577, valued at
$47.9k
|
|
| 03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/13/2023 |
4
| Ward Shane (COO & CLO) has filed a Form 4 on Cidara Therapeutics, Inc.|
Txns:
| Sold 4,329 shares
@ $1.53, valued at
$6.6k
|
|
| 03/13/2023 |
4
| Tari Leslie (CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on Cidara Therapeutics, Inc.|
Txns:
| Sold 7,562 shares
@ $1.53, valued at
$11.6k
|
|
| 03/13/2023 |
4
| Shah Preetam (CFO & CBO) has filed a Form 4 on Cidara Therapeutics, Inc.|
Txns:
| Sold 6,648 shares
@ $1.53, valued at
$10.2k
|
|
| 03/13/2023 |
4
| Sandison Taylor (Chief Medical Officer) has filed a Form 4 on Cidara Therapeutics, Inc.|
Txns:
| Sold 7,203 shares
@ $1.53, valued at
$11k
|
|
| 01/27/2023 |
4
| Tari Leslie (CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on Cidara Therapeutics, Inc.|
Txns:
| Sold 11,814 shares
@ $1.2, valued at
$14.2k
|
|
| 09/19/2022 |
4
| Shah Preetam (CFO & CBO) has filed a Form 4 on Cidara Therapeutics, Inc.|
Txns:
| Sold 15,642 shares
@ $0.7694, valued at
$12k
Exercised 50,000 restricted stock units
@ $0 |
|
| 09/13/2022 |
4
| Sandison Taylor (Chief Medical Officer) has filed a Form 4 on Cidara Therapeutics, Inc.|
Txns:
| Sold 18,478 shares
@ $0.6849, valued at
$12.7k
|
|
| 09/13/2022 |
4
| Tari Leslie (CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on Cidara Therapeutics, Inc.|
Txns:
| Sold 18,159 shares
@ $0.6849, valued at
$12.4k
|
|
| 09/13/2022 |
4
| Daruwala Paul (COO) has filed a Form 4 on Cidara Therapeutics, Inc.|
Txns:
| Sold 16,199 shares
@ $0.6849, valued at
$11.1k
|
|
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Bassler Bonnie L (Director) has filed a Form 4 on Cidara Therapeutics, Inc.|
Txns:
| Granted 28,000 options to buy
@ $0.53, valued at
$14.8k
|
|
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/04/2022 |
4
| Johnson Brady (Vice President, Finance) has filed a Form 4 on Cidara Therapeutics, Inc.|
Txns:
| Granted 10,000 shares
@ $0
Granted 20,000 options to buy
@ $0.83, valued at
$16.6k
|
|
| 04/04/2022 |
4
| Shah Preetam (CFO & CBO) has filed a Form 4 on Cidara Therapeutics, Inc.|
Txns:
| Granted 51,250 shares
@ $0
Granted 66,001 shares
@ $0
Paid exercise price by delivering 24,820 shares
@ $0.83, valued at
$20.6k
Granted 102,500 options to buy
@ $0.83, valued at
$85.1k
|
|
| 04/04/2022 |
4
| Sandison Taylor (Chief Medical Officer) has filed a Form 4 on Cidara Therapeutics, Inc.|
Txns:
| Granted 50,000 shares
@ $0
Granted 100,000 options to buy
@ $0.83, valued at
$83k
|
|
| 04/04/2022 |
4
| Ward Shane (CHIEF LEGAL OFFICER) has filed a Form 4 on Cidara Therapeutics, Inc.|
Txns:
| Granted 35,000 shares
@ $0
Granted 69,027 shares
@ $0
Paid exercise price by delivering 23,122 shares
@ $0.83, valued at
$19.2k
Granted 70,000 options to buy
@ $0.83, valued at
$58.1k
|
|
| 04/04/2022 |
4
| Stein Jeffrey (President & CEO) has filed a Form 4 on Cidara Therapeutics, Inc.|
Txns:
| Granted 165,000 shares
@ $0
Granted 408,742 shares
@ $0
Paid exercise price by delivering 140,985 shares
@ $0.83, valued at
$117k
Granted 330,000 options to buy
@ $0.83, valued at
$273.9k
|
|
| 04/04/2022 |
4
| Tari Leslie (CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on Cidara Therapeutics, Inc.|
Txns:
| Granted 52,500 shares
@ $0
Granted 105,000 options to buy
@ $0.83, valued at
$87.2k
|
|
| 04/04/2022 |
4
| Daruwala Paul (COO) has filed a Form 4 on Cidara Therapeutics, Inc.|
Txns:
| Granted 50,000 shares
@ $0
Granted 100,000 options to buy
@ $0.83, valued at
$83k
|
|
| 03/23/2022 |
4
| Johnson Brady (Vice President, Finance) has filed a Form 4 on Cidara Therapeutics, Inc.|
Txns:
| Sold 654 shares
@ $0.81, valued at
$529.7 |
|
| 03/11/2022 |
4
| Johnson Brady (Vice President, Finance) has filed a Form 4 on Cidara Therapeutics, Inc.|
Txns:
| Sold 945 shares
@ $0.71, valued at
$671 |
|
| 01/07/2022 |
4
| Daruwala Paul (COO) has filed a Form 4 on Cidara Therapeutics, Inc.|
Txns:
| Sold 5,133 shares
@ $1.25, valued at
$6.4k
Exercised 5,000 restricted stock units
@ $0
Exercised 4,900 restricted stock units
@ $0 |
|
|
|
|